ARCHIVES

ODAC Meets at ASCO, Recommends Approval Of Dasatinib For CML.

This article is from The Cancer Letter archive.

Vol. 32 No. 22 | June 9, 2006

Download PDF Visit The Full Archive

Related Articles

FDA Approves Implant For Breast Reconstruction

July 26, 2013

Clinical Study Group Proposed To Examine Peer Review System

October 15, 1993

No Interest Seen Yet In Specialized Centers For Environmental Carcinogenesis

September 26, 1975

NCI Dispute GAO Charge That Cancer Control Contracts Were Mishandled

August 15, 1980

Broder Encourages Support Of Drug Development Programs

March 10, 1995

Cohen Directs UK’s Markey Cancer Center; Matrisian Named Chairman, DOD Panel.

September 8, 2000